Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01071369 · ClinicalTrials.gov registry record · Phase 4

Treatment of Chronic Thoracic and Neck and Upper Extremity Pain

A Phase 4 study, sponsored by Pain Management Center of Paducah.

Completed
Registry status
Phase 4
Development phase
120
Enrollment target

NCT01071369 is a Phase 4 study that has completed, run by Pain Management Center of Paducah. The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01071369, a Phase 4 study, has completed, sponsored by Pain Management Center of Paducah.

COMPLETED
Registry status
Phase 4
Development phase
120 participants
Enrollment target

Study Summary

To study improvements or lack thereof with the interlaminar epidural patients with or without steroids experiences mid back, upper back or neck pain with or without chest wall and upper extremity pain of at least 6-months duration non-responsive to conservative management.

Interventions

  • DRUG Xylocaine
  • DRUG Xylocaine and Celestone

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2008-02
Est. Completion 2012-06
Phase Phase 4

Sponsor

Pain Management Center of Paducah

11 total trials

What the Registry Record Tells You About NCT01071369

The ClinicalTrials.gov registry entry for NCT01071369 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pain Management Center of Paducah, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Xylocaine is the first listed.

NCT01071369 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01071369 about?

NCT01071369 is a clinical study titled "Treatment of Chronic Thoracic and Neck and Upper Extremity Pain". To study improvements or lack thereof with the interlaminar epidural patients with or without steroids experiences mid back, upper back or neck pain with or without chest wall and upper extremity pain of at least 6-months duration non-responsive to conservative management.

What is the current status of trial NCT01071369?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2008-02. Estimated completion is 2012-06.

What interventions are being tested in trial NCT01071369?

The interventions under investigation include: Xylocaine (DRUG), Xylocaine and Celestone (DRUG).

Who is sponsoring clinical trial NCT01071369?

This trial is sponsored by Pain Management Center of Paducah, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.